Enveric Biosciences to Present at H.C. Wainwright 25th Annual Global ConferencePosted by On

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, today announced that Joseph Tucker, Ph.D., Chief Executive Officer, will deliver a virtual presentation at the H.C. Wainwright 25th Wainwright Global Conference taking place from September 11 – 13, 2023. Details of Enveric’s

Source link

USDA Certified Organic Tinctures and salves


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.